Mineralys Therapeutics
MLYS
MLYS
108 hedge funds and large institutions have $572M invested in Mineralys Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 44 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 106 → 108 (+2)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
88% less call options, than puts
Call options by funds: $1K | Put options by funds: $8K
Holders
108
Holding in Top 10
7
Calls
$1K
Puts
$8K
Top Buyers
| 1 | +$12.3M | |
| 2 | +$6.39M | |
| 3 | +$5.94M | |
| 4 |
SC
Stempoint Capital
New York
|
+$4.93M |
| 5 |
Jennison Associates
New York
|
+$4.75M |
Top Sellers
| 1 | -$7.27M | |
| 2 | -$4.96M | |
| 3 | -$4.82M | |
| 4 |
BOCH
Blue Owl Capital Holdings
New York
|
-$2.38M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.51M |